Developer docs
API playgroundTry for free, no card

Search company profiles

THE RYR-1 FOUNDATION

Full company profile

uuid00ynfoi

Namestring
THE RYR-1 FOUNDATION
Legal namestring
The RYR-1 Foundation
Websiteurl
ryr1.org
Company typeenum
Private
Founded yearint
2014
Descriptiontext

The RYR-1 Foundation is a Pittsburgh-based, 501(c)(3) public charity founded in 2016 by the Goldberg Family to serve as the sole organization dedicated to advocating for patients and families affected by RYR-1-Related Diseases (RYR-1-RD) — a group of rare genetic conditions involving skeletal muscle calcium regulation that include malignant hyperthermia susceptibility, congenital myopathies, and rhabdomyolysis. It was created to fill a void, as the foundation states that no other organization existed solely to advocate for and serve this patient population at the time of founding.

The foundation's core offerings center on patient and research infrastructure rather than commercial products: a free, multilingual Clinical Care Guidelines resource available in 10+ languages (English, Spanish, Vietnamese, Chinese, French, German, Arabic, Russian, Brazilian Portuguese); international Family Conferences convening affected individuals, families, researchers, and medical professionals; a Research Grants Program funding investigator-led studies; a Patient Registry that aggregates affected-individual data for research use; Research Workshops for the scientific community; RYR-1-RD mice research models supporting preclinical studies; and a Video Gallery plus monthly newsletter for community education. It also participates in Rare Disease Week on Capitol Hill for federal advocacy.

The foundation is governed by a 9-member Board of Directors and supported by a Scientific Advisory Board that includes clinicians and researchers from the University Health Network, NIH/NINDS, and Neurocrine Biosciences. Co-founders Lindsay Goldberg, BSN, RN (Executive Director & Patient Liaison) and Dr. Michael F. Goldberg, MD, MPH (President, Board of Directors and Co-Chair of Research) lead day-to-day operations along with a single Program Manager. Revenue is generated exclusively through tax-deductible donations and fundraising activities (individual giving, end-of-year and GivingTuesday campaigns, hosted fundraisers, and corporate partnerships such as the Seattle Seahawks My Cause My Cleats campaign). All patient resources are provided free of charge, and the foundation works with affected families, researchers, biotech/pharma companies, and healthcare providers across the globe to facilitate communication, fund research, advance therapies, and optimize standards of care.

Short descriptiontext

The RYR-1 Foundation is a Pittsburgh-based 501(c)(3) public charity founded in 2016 that serves as the sole patient advocacy organization for individuals and families affected by RYR-1-Related Diseases, funding research, publishing multilingual Clinical Care Guidelines, hosting international Family Conferences, and operating a Patient Registry globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPittsburgh, United States
HQ citystring
Pittsburgh
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare disease advocacy, patient support services, research grant funding, clinical care guidelines, family conference events
Industry3 codes
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
NAICS code1 code
  • Voluntary Health Organizations813212
SIC code2 codes
  • Services-Social Services8300
  • Services-Membership Organizations8600
Product category
Rare Disease Patient Advocacy
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Fundraising
TypeOthers
Description

As a 501(c)(3) non-profit public charity, the foundation generates revenue primarily through tax-deductible donations from individuals, families, and corporate sponsors. Fundraising activities include end-of-year giving campaigns, GivingTuesday campaigns, hosted fundraisers, and the My Cause My Cleats campaign partnership with Seattle Seahawks.

ryr1.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Others, Technology or R&D
Pricing details1 tier
1Free access to all foundation resources
ModelFreemiumBilling cadenceOthers
Notes

All patient and family resources, Clinical Care Guidelines, webinars, and educational materials are provided free of charge. The foundation operates on donation-based funding.

ryr1.org
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

The RYR-1 Foundation is a non-profit patient advocacy organization that funds research, provides multilingual Clinical Care Guidelines, hosts International Family Conferences, operates a patient registry, runs research workshops, and delivers educational and support resources for patients and families affected by RYR-1-Related Diseases (RYR-1-RD). All patient-facing resources are provided free of charge, with operations sustained through donations, fundraising, and grants.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Provided over $6,675 raised through Seattle Seahawks My Cause My Cleats partnership
+1 more record
Product overview1 text field

The RYR-1 Foundation operates as a unified patient advocacy and research support organization rather than a platform-plus-modules product architecture. The foundation's core offerings center on the Clinical Care Guidelines (a free multilingual guide), the International Family Conferences, Research Grants Program, Patient Registry, Research Workshops, RYR-1-RD Mice research models, and the Video Gallery. These services collectively serve affected patients and families, researchers, biotech and pharmaceutical partners, and healthcare providers to facilitate communication, fund research, advance therapies, and optimize standards of care for RYR-1-Related Diseases.

Product and service9 records
1Clinical Care Guidelines
CategoryEducational Resource
Description

A free, multilingual informative guide providing practical and accessible information for individuals and families affected by RYR-1-Related Diseases, covering care standards, disease management, and resources for patients, families, and healthcare providers. Available in 10+ languages including English, Spanish, Vietnamese, Chinese, French, German, Arabic, Russian, and Portuguese-BR.

2RYR-1 International Family Conferences
CategoryCommunity Events / Conferences
Description

International conferences bringing together affected individuals, families, researchers, and healthcare providers to share knowledge, build community, and advance understanding of RYR-1-Related Diseases. The foundation's homepage impact counter tracks the number of conferences hosted.

3RYR-1-RD Research Grants Program
CategoryResearch Funding Program
Description

Grant program funding innovative research to advance treatments and cures for RYR-1-Related Diseases, including Individual Investigator Research Grant Awards supporting high-impact basic science and clinical research. Funded research has resulted in publications in Nature Communications and other peer-reviewed journals.

4RYR-1-RD Patient Registry
CategoryPatient Registry / Research Platform
Description

A registry program enabling affected individuals to join and contribute data that supports research and connects the RYR-1-RD community. Patients enroll online to provide data that supports research, clinical trial recruitment, and the broader RYR-1-RD community.

5RYR-1-RD Research Workshops
CategoryResearch Convening / Events
Description

Periodic workshops convening researchers and scientists to discuss RYR-1-Related Disease research progress, share findings, and identify research priorities within the RYR-1-RD research community.

6RYR-1-RD Mice (Research Models)
CategoryResearch Models
Description

Animal models developed or utilized for RYR-1-Related Disease research, supporting preclinical studies and therapeutic development for the RYR-1-RD research community.

7Patient & Family Resources
CategoryEducational Resource Hub
Description

Comprehensive resource hub providing educational materials, support information, and guidance for individuals and families affected by RYR-1-Related Diseases, including information on genetic testing, locating providers, and disease management.

8Video Gallery
CategoryEducational Content
Description

Educational and informational video content related to RYR-1-Related Diseases, featuring patient stories, medical information, and educational presentations for the RYR-1-RD community.

9RYR-1 Foundation Monthly Newsletter
CategoryCommunications / Newsletter
Description

Monthly digital newsletter keeping the RYR-1-RD community informed about research updates, events, advocacy opportunities, and foundation activities; available via email subscription.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1Fly Penguins Fly Podcast
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-11-01
Description

The foundation was featured on the Fly Penguins Fly Podcast in a special episode featuring community member Cody Hodgson, an NHL ice hockey player living with Malignant Hyperthermia caused by an RYR1 variant. The episode also featured Dr. Sheila Riazi, Dr. Michael Goldberg, and Lindsay Goldberg discussing RYR-1-RD research and community impact.

ryr1.org
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-01-01
Description

Seattle Seahawks Head Coach Mike Macdonald selected The RYR-1 Foundation as beneficiary for My Cause My Cleats campaign for the second consecutive year. The cause is personal to Coach Macdonald as his nephew Lucas lives with a RYR-1-RD. This partnership raised $6,675 for the foundation.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Triage Health, an educational program of the nonprofit Triage Cancer, partners with the foundation to offer free webinars helping rare disease patients understand legal and practical aspects of navigating healthcare, including health insurance, disability benefits, employment rights, and medical bills.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NIH conducts an ongoing Natural History Study on RYR-1-Related Disorders (Research Study #001737-CC) led by Tokunbor A. Lawal, PhD, FNP-BC. The foundation encourages eligible patients to participate in this critical research. NIH's Dr. Joshua Todd also served as an investigator on early clinical trials for RYR1-related disorders.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Dr. Nick Kruijt, a neurologist and researcher at Radboudumc in the Netherlands, published research on thermoregulation in individuals with RYR1-related malignant hyperthermia or exertional heat stroke. The study was funded by The RYR-1 Foundation.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Joshua J. Todd, PhD, MBA serves as Scientific Director, Clinical Development at Neurocrine Biosciences. Dr. Todd is a new member of the foundation's Scientific Advisory Board and brings expertise in clinical development for rare neuromuscular diseases.

Strategic tierMinorTypeGTM or Marketing Partner
Description

The foundation participates in Rare Disease Week on Capitol Hill organized by the EveryLife Foundation, using hashtag #RareDC2026 to join the advocacy conversation and connect with policymakers.

Strategic tierMinorTypeGTM or Marketing Partner
Description

The foundation highlights NORD's RareCare Patient Assistance Programs as a valuable resource for the rare disease community, helping individuals access medications, diagnostic testing, travel support, and financial assistance.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Umbrella rare-disease advocacy organization that the RYR-1 Foundation already partners with for RareCare Patient Assistance Programs. Operates as a federating body and policy advocate for rare disease communities.

2Malignant Hyperthermia Association of the United States (MHAUS)
TypeDirect peer
Description

Patient advocacy organization dedicated to malignant hyperthermia—one of the RYR-1-RD phenotypes directly addressed by the RYR-1 Foundation. Sheila Riazi of the Foundation's SAB sits on MHAUS's board, evidencing close overlap.

TypeDirect peer
Description

Canadian-based rare disease advocacy and research funding organization that supports multiple rare diseases through community grants and partnerships. Comparable as a small-scale rare disease advocacy and research funder.

TypeOthers
Description

Nonprofit that provides free education on cancer and rare-disease legal, financial, and practical issues via webinars and resources. Directly comparable as the operator of the Triage Health program through which the RYR-1 Foundation delivers educational webinars.

TypeDirect peer
Description

Family-driven ultra-rare disease advocacy organization that funds research, hosts conferences, and supports patients/families. Comparable as a small, family-led nonprofit serving a single ultra-rare genetic disease community.

TypeBroad incumbent
Description

Large incumbent neuromuscular disease advocacy organization that funds research, supports patients, and runs clinical care programs across multiple myopathies including RYR-1-related conditions. Directly comparable as a rare-neuromuscular disease funder and patient advocate.

TypeDirect peer
Description

Public policy advocacy organization for the rare disease community that organizes Rare Disease Week on Capitol Hill, which the RYR-1 Foundation actively participates in. Both serve as advocacy and policy organizations for rare disease patients.

TypeDirect peer
Description

Disease-specific rare neuromuscular advocacy organization that funds research, runs family conferences, and supports patient registries. Highly comparable operating model to the RYR-1 Foundation in serving a single rare disease community.

TypeDirect peer
Description

Family-founded rare disease advocacy organization supporting Duchenne muscular dystrophy patients with research funding, clinical care guidelines, and advocacy. Structurally and operationally very similar to the RYR-1 Foundation's model.

TypeBroad incumbent
Description

Professional medical society supporting clinicians and researchers in neuromuscular medicine, including RYR-1-RD. Comparable as a convener of clinicians/researchers and source of clinical care standards in the same disease space.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

THE RYR-1 FOUNDATION

Rare Disease Patient Advocacyryr1.org

The RYR-1 Foundation is a Pittsburgh-based 501(c)(3) public charity founded in 2016 that serves as the sole patient advocacy organization for individuals and families affected by RYR-1-Related Diseases, funding research, publishing multilingual Clinical Care Guidelines, hosting international Family Conferences, and operating a Patient Registry globally.

What THE RYR-1 FOUNDATION does

The RYR-1 Foundation is a Pittsburgh-based, 501(c)(3) public charity founded in 2016 by the Goldberg Family to serve as the sole organization dedicated to advocating for patients and families affected by RYR-1-Related Diseases (RYR-1-RD) — a group of rare genetic conditions involving skeletal muscle calcium regulation that include malignant hyperthermia susceptibility, congenital myopathies, and rhabdomyolysis. It was created to fill a void, as the foundation states that no other organization existed solely to advocate for and serve this patient population at the time of founding.

The foundation's core offerings center on patient and research infrastructure rather than commercial products: a free, multilingual Clinical Care Guidelines resource available in 10+ languages (English, Spanish, Vietnamese, Chinese, French, German, Arabic, Russian, Brazilian Portuguese); international Family Conferences convening affected individuals, families, researchers, and medical professionals; a Research Grants Program funding investigator-led studies; a Patient Registry that aggregates affected-individual data for research use; Research Workshops for the scientific community; RYR-1-RD mice research models supporting preclinical studies; and a Video Gallery plus monthly newsletter for community education. It also participates in Rare Disease Week on Capitol Hill for federal advocacy.

The foundation is governed by a 9-member Board of Directors and supported by a Scientific Advisory Board that includes clinicians and researchers from the University Health Network, NIH/NINDS, and Neurocrine Biosciences. Co-founders Lindsay Goldberg, BSN, RN (Executive Director & Patient Liaison) and Dr. Michael F. Goldberg, MD, MPH (President, Board of Directors and Co-Chair of Research) lead day-to-day operations along with a single Program Manager. Revenue is generated exclusively through tax-deductible donations and fundraising activities (individual giving, end-of-year and GivingTuesday campaigns, hosted fundraisers, and corporate partnerships such as the Seattle Seahawks My Cause My Cleats campaign). All patient resources are provided free of charge, and the foundation works with affected families, researchers, biotech/pharma companies, and healthcare providers across the globe to facilitate communication, fund research, advance therapies, and optimize standards of care.

THE RYR-1 FOUNDATION firmographics

Firmographics
Name
THE RYR-1 FOUNDATION
Legal name
The RYR-1 Foundation
Website
https://ryr1.org
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
The RYR-1 Foundation is a Pittsburgh-based 501(c)(3) public charity founded in 2016 that serves as the sole patient advocacy organization for individuals and families affected by RYR-1-Related Diseases, funding research, publishing multilingual Clinical Care Guidelines, hosting international Family Conferences, and operating a Patient Registry globally.
Ownership category
akta.pro rank

THE RYR-1 FOUNDATION industry classification

Industry
Product category
Rare Disease Patient Advocacy
NAICS
Voluntary Health Organizations (813212)
SIC
Services-Social Services (8300), Services-Membership Organizations (8600)
akta.pro industry
PRIMARYBPAGACAM
Rare Disease & Special Needs Support Organizations
SECONDARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking

Keywords

  • Rare disease advocacy
  • Patient support services
  • Research grant funding
  • Clinical care guidelines
  • Family conference events

Where THE RYR-1 FOUNDATION is headquartered

Location

Headquarters

HQ city
Pittsburgh
HQ country
United States
HQ region
North America

Offices1 record

Markets served

THE RYR-1 FOUNDATION business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others, Technology or R&D

Revenue model

  1. Donations and Fundraising: As a 501(c)(3) non-profit public charity, the foundation generates revenue primarily through tax-deductible donations from individuals, families, and corporate sponsors. Fundraising activities include end-of-year giving campaigns, GivingTuesday campaigns, hosted fundraisers, and the My Cause My Cleats campaign partnership with Seattle Seahawks.

Pricing tiers

ModelBillingPrice
FreemiumOthersFree access to all foundation resources

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

THE RYR-1 FOUNDATION product offering

Product offering

Core offering

The RYR-1 Foundation is a non-profit patient advocacy organization that funds research, provides multilingual Clinical Care Guidelines, hosts International Family Conferences, operates a patient registry, runs research workshops, and delivers educational and support resources for patients and families affected by RYR-1-Related Diseases (RYR-1-RD). All patient-facing resources are provided free of charge, with operations sustained through donations, fundraising, and grants.

Product overview

The RYR-1 Foundation operates as a unified patient advocacy and research support organization rather than a platform-plus-modules product architecture. The foundation's core offerings center on the Clinical Care Guidelines (a free multilingual guide), the International Family Conferences, Research Grants Program, Patient Registry, Research Workshops, RYR-1-RD Mice research models, and the Video Gallery. These services collectively serve affected patients and families, researchers, biotech and pharmaceutical partners, and healthcare providers to facilitate communication, fund research, advance therapies, and optimize standards of care for RYR-1-Related Diseases.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Care Guidelines A free, multilingual informative guide providing practical and accessible information for individuals and families affected by RYR-1-Related Diseases, covering care standards, disease management, and resources for patients, families, and healthcare providers. Available in 10+ languages including English, Spanish, Vietnamese, Chinese, French, German, Arabic, Russian, and Portuguese-BR.
  • RYR-1 International Family Conferences International conferences bringing together affected individuals, families, researchers, and healthcare providers to share knowledge, build community, and advance understanding of RYR-1-Related Diseases. The foundation's homepage impact counter tracks the number of conferences hosted.
  • RYR-1-RD Research Grants Program Grant program funding innovative research to advance treatments and cures for RYR-1-Related Diseases, including Individual Investigator Research Grant Awards supporting high-impact basic science and clinical research. Funded research has resulted in publications in Nature Communications and other peer-reviewed journals.
  • RYR-1-RD Patient Registry A registry program enabling affected individuals to join and contribute data that supports research and connects the RYR-1-RD community. Patients enroll online to provide data that supports research, clinical trial recruitment, and the broader RYR-1-RD community.
  • RYR-1-RD Research Workshops Periodic workshops convening researchers and scientists to discuss RYR-1-Related Disease research progress, share findings, and identify research priorities within the RYR-1-RD research community.
  • RYR-1-RD Mice (Research Models) Animal models developed or utilized for RYR-1-Related Disease research, supporting preclinical studies and therapeutic development for the RYR-1-RD research community.
  • Patient & Family Resources Comprehensive resource hub providing educational materials, support information, and guidance for individuals and families affected by RYR-1-Related Diseases, including information on genetic testing, locating providers, and disease management.
  • Video Gallery Educational and informational video content related to RYR-1-Related Diseases, featuring patient stories, medical information, and educational presentations for the RYR-1-RD community.
  • RYR-1 Foundation Monthly Newsletter Monthly digital newsletter keeping the RYR-1-RD community informed about research updates, events, advocacy opportunities, and foundation activities; available via email subscription.

Quantifiable outcome

  • Provided over $6,675 raised through Seattle Seahawks My Cause My Cleats partnership
  • +1 more outcomes

Companies that use THE RYR-1 FOUNDATION

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

THE RYR-1 FOUNDATION technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

THE RYR-1 FOUNDATION partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered minor and core.

  • Fly Penguins Fly PodcastminorGTM or Marketing Partner · 1 November 2025The foundation was featured on the Fly Penguins Fly Podcast in a special episode featuring community member Cody Hodgson, an NHL ice hockey player living with Malignant Hyperthermia caused by an RYR1 variant. The episode also featured Dr. Sheila Riazi, Dr. Michael Goldberg, and Lindsay Goldberg discussing RYR-1-RD research and community impact.
  • Seattle Seahawks (Mike Macdonald)minorGTM or Marketing Partner · 1 January 2025Seattle Seahawks Head Coach Mike Macdonald selected The RYR-1 Foundation as beneficiary for My Cause My Cleats campaign for the second consecutive year. The cause is personal to Coach Macdonald as his nephew Lucas lives with a RYR-1-RD. This partnership raised $6,675 for the foundation.
  • Triage HealthminorGTM or Marketing PartnerTriage Health, an educational program of the nonprofit Triage Cancer, partners with the foundation to offer free webinars helping rare disease patients understand legal and practical aspects of navigating healthcare, including health insurance, disability benefits, employment rights, and medical bills.
  • National Institutes of Health (NIH)coreStrategic or Co-development PartnerNIH conducts an ongoing Natural History Study on RYR-1-Related Disorders (Research Study #001737-CC) led by Tokunbor A. Lawal, PhD, FNP-BC. The foundation encourages eligible patients to participate in this critical research. NIH's Dr. Joshua Todd also served as an investigator on early clinical trials for RYR1-related disorders.
  • Radboud University Medical Centre (Radboudumc)minorStrategic or Co-development PartnerDr. Nick Kruijt, a neurologist and researcher at Radboudumc in the Netherlands, published research on thermoregulation in individuals with RYR1-related malignant hyperthermia or exertional heat stroke. The study was funded by The RYR-1 Foundation.
  • Neurocrine Biosciences Inc.minorStrategic or Co-development PartnerJoshua J. Todd, PhD, MBA serves as Scientific Director, Clinical Development at Neurocrine Biosciences. Dr. Todd is a new member of the foundation's Scientific Advisory Board and brings expertise in clinical development for rare neuromuscular diseases.
  • EveryLife FoundationminorGTM or Marketing PartnerThe foundation participates in Rare Disease Week on Capitol Hill organized by the EveryLife Foundation, using hashtag #RareDC2026 to join the advocacy conversation and connect with policymakers.
  • NORD (National Organization for Rare Disorders)minorGTM or Marketing PartnerThe foundation highlights NORD's RareCare Patient Assistance Programs as a valuable resource for the rare disease community, helping individuals access medications, diagnostic testing, travel support, and financial assistance.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

THE RYR-1 FOUNDATION competitors and assessment

Company assessment

Broad incumbents

  • National Organization for Rare Disorders (NORD): Umbrella rare-disease advocacy organization that the RYR-1 Foundation already partners with for RareCare Patient Assistance Programs. Operates as a federating body and policy advocate for rare disease communities.
  • Muscular Dystrophy Association (MDA): Large incumbent neuromuscular disease advocacy organization that funds research, supports patients, and runs clinical care programs across multiple myopathies including RYR-1-related conditions. Directly comparable as a rare-neuromuscular disease funder and patient advocate.
  • AANEM (American Association of Neuromuscular & Electrodiagnostic Medicine): Professional medical society supporting clinicians and researchers in neuromuscular medicine, including RYR-1-RD. Comparable as a convener of clinicians/researchers and source of clinical care standards in the same disease space.

Direct peers

  • Malignant Hyperthermia Association of the United States (MHAUS): Patient advocacy organization dedicated to malignant hyperthermia—one of the RYR-1-RD phenotypes directly addressed by the RYR-1 Foundation. Sheila Riazi of the Foundation's SAB sits on MHAUS's board, evidencing close overlap.
  • Rare Disease Foundation: Canadian-based rare disease advocacy and research funding organization that supports multiple rare diseases through community grants and partnerships. Comparable as a small-scale rare disease advocacy and research funder.
  • AHC Foundation (Alternating Hemiplegia of Childhood): Family-driven ultra-rare disease advocacy organization that funds research, hosts conferences, and supports patients/families. Comparable as a small, family-led nonprofit serving a single ultra-rare genetic disease community.
  • EveryLife Foundation: Public policy advocacy organization for the rare disease community that organizes Rare Disease Week on Capitol Hill, which the RYR-1 Foundation actively participates in. Both serve as advocacy and policy organizations for rare disease patients.
  • CureSMA (Spinal Muscular Atrophy): Disease-specific rare neuromuscular advocacy organization that funds research, runs family conferences, and supports patient registries. Highly comparable operating model to the RYR-1 Foundation in serving a single rare disease community.
  • Parent Project Muscular Dystrophy (PPMD): Family-founded rare disease advocacy organization supporting Duchenne muscular dystrophy patients with research funding, clinical care guidelines, and advocacy. Structurally and operationally very similar to the RYR-1 Foundation's model.

Others

  • Triage Cancer: Nonprofit that provides free education on cancer and rare-disease legal, financial, and practical issues via webinars and resources. Directly comparable as the operator of the Triage Health program through which the RYR-1 Foundation delivers educational webinars.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

THE RYR-1 FOUNDATION social profiles

Digital presence

THE RYR-1 FOUNDATION financial estimates

Financial estimate

Revenue estimate

Valuation estimate

THE RYR-1 FOUNDATION leadership team

Management profile

Number of profiles

Profiles12 records

THE RYR-1 FOUNDATION funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

THE RYR-1 FOUNDATION M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about THE RYR-1 FOUNDATION

What does THE RYR-1 FOUNDATION do?

The RYR-1 Foundation is a non-profit patient advocacy organization that funds research, provides multilingual Clinical Care Guidelines, hosts International Family Conferences, operates a patient registry, runs research workshops, and delivers educational and support resources for patients and families affected by RYR-1-Related Diseases (RYR-1-RD). All patient-facing resources are provided free of charge, with operations sustained through donations, fundraising, and grants.

Is THE RYR-1 FOUNDATION a public or private company?

THE RYR-1 FOUNDATION is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was THE RYR-1 FOUNDATION founded?

THE RYR-1 FOUNDATION was founded in 2014. It employs 1 to 10 people.

Where is THE RYR-1 FOUNDATION based?

THE RYR-1 FOUNDATION is headquartered in Pittsburgh, United States, in the North America region.

How does THE RYR-1 FOUNDATION make money?

One revenue line is on record: donations and Fundraising.

Who are THE RYR-1 FOUNDATION's main competitors?

Broad incumbents on record are National Organization for Rare Disorders (NORD), Muscular Dystrophy Association (MDA) and AANEM (American Association of Neuromuscular & Electrodiagnostic Medicine). Direct peers are Malignant Hyperthermia Association of the United States (MHAUS), Rare Disease Foundation, AHC Foundation (Alternating Hemiplegia of Childhood), EveryLife Foundation, CureSMA (Spinal Muscular Atrophy) and Parent Project Muscular Dystrophy (PPMD). Triage Cancer is listed as an others.

Does THE RYR-1 FOUNDATION have an API?

No public API is recorded for THE RYR-1 FOUNDATION.

What industry is THE RYR-1 FOUNDATION in?

THE RYR-1 FOUNDATION's product category is Rare Disease Patient Advocacy. Its primary akta.pro industry code is BPAGACAM, Rare Disease & Special Needs Support Organizations, with a secondary code of BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813212 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals